Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways
about
Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinasesNovel non-AR therapeutic targets in castrate resistant prostate cancerRhodium(II) metallopeptide catalyst design enables fine control in selective functionalization of natural SH3 domains.Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.Can we unlock the potential of IGF-1R inhibition in cancer therapy?Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549.Novel C6-substituted 1,3,4-oxadiazinones as potential anti-cancer agents.Ligand-independent activation of MET through IGF-1/IGF-1R signaling.Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation.Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studiesc-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.Increased serum insulin-like growth factor-1 levels are associated with prolonged response to dasatinib-based regimens in metastatic prostate cancer.BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo.Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer.Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity.
P2860
Q26866135-B0B023D9-0E4E-4837-B01A-773660AC8F77Q28383663-B58F6711-2936-4434-B3DF-63477E9B9AC9Q30009229-FADEFB8D-8971-475D-927D-393AD19C7D66Q30458494-CC822357-3794-40AF-98BD-60870CC55D3CQ34336988-0880CBED-B600-4FAF-8137-492575DDB9CFQ35832949-DE5C9F1A-0524-4119-B172-CB348236C6DEQ35940305-9ED00EDB-54E3-4CA3-8DA3-225CFD7148D6Q36562098-6056832A-493D-46D0-BB9F-309E96D6D35FQ37018397-C37A0767-1CCE-48D8-8ED0-5AE553CFD56DQ37565014-920E1CA0-9483-4B98-8B0D-0527A97D299FQ37583421-A1F6709D-6E72-462A-BEB5-4DA0409C0A0BQ38641329-0E66FD70-916F-4E3B-ACF3-61953D57CBA1Q38768131-A43FB6F7-58EB-447D-AD7A-CA65BF4990A9Q39201195-BB054DCD-247A-446F-87A3-D7E0891EE1EDQ39620395-9FE8F4AE-E24C-4903-8CDC-D098A07F1BB3Q41474636-D435E6D7-6235-47C9-864C-58610C6F6FC7Q49887912-5226E81D-B0CA-4D92-B7CF-468EDD380690
P2860
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@ast
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@en
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@nl
type
label
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@ast
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@en
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@nl
prefLabel
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@ast
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@en
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@nl
P2093
P2860
P3181
P1433
P1476
Combined Inhibition of IGF-1R/ ...... ng activated survival pathways
@en
P2093
Adam R Wolfe
Andreas S Varkaris
Christopher J Logothetis
Farshid Dayyani
Gary E Gallick
Jian H Song
Joan M Carboni
Marco M Gottardis
Nila U Parikh
Sankar N Maity
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0051189
P407
P577
2012-01-01T00:00:00Z